Trademark Attorney / Law Firm
Michael R. Spillane – Trademark Portfolio
Michael R. Spillane has filed 9 trademarks with the United States Patent and Trademark Office (USPTO). Filing records span from 2012 to 2016, covering 5 years of intellectual property practice. The portfolio covers 6 Nice Classification classes, with the highest concentration in Class 42 (Computer & Scientific, 4 filings) and Class 35 (Advertising & Business, 2 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Michael R. Spillane's trademark practice covers 6 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has Michael R. Spillane filed?
Michael R. Spillane has filed 9 trademark applications with the United States Patent and Trademark Office (USPTO).
What trademark classes does Michael R. Spillane specialize in?
Michael R. Spillane has filed trademarks across 6 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 25 (Clothing), Class 41 (Education & Entertainment), Class 43 (Hotels & Restaurants). Class 42 covers scientific and technological services; industrial analysis and research services.
How long has Michael R. Spillane been filing trademarks?
Michael R. Spillane's trademark filing history with the USPTO spans from 2012 to 2016, covering 4 years of trademark practice. During this period, Michael R. Spillane has handled 9 trademark applications.
What is Michael R. Spillane's trademark registration success rate?
Michael R. Spillane has a 0% trademark registration rate, with 0 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.